Blood plasma derivatives are medicinal preparations obtained from human blood plasma. Some key blood plasma derivatives include immunoglobulins, coagulation factor concentrates, albumin, and hyperimmune globulins. These derivatives find wide therapeutic applications in the treatment of immune deficiencies, bleeding disorders, shock, burns, and other conditions. Immunoglobulins are used for treating primary immunodeficiencies and neurological disorders while albumin finds its primary use in treatment of shock and burns. Coagulation factor concentrates help treat hemophilia and other bleeding disorders.

The global blood plasma derivatives market is estimated to be valued at US$ 51.07 Bn  in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics
The rising demand for therapeutic applications of blood plasma derivatives is the primary driver fueling growth of the global blood plasma derivatives market. According to the World Federation of Hemophilia, hemophilia afflicts about one in every 10,000 male births, requiring lifelong treatment with coagulation factor concentrates. In addition, growing prevalence of immunodeficiency and neurological disorders worldwide is also propelling utilization of immunoglobulins. For instance, according to the American Autoimmune Related Diseases Association, autoimmune diseases afflict 14.7% of the U.S. population. Furthermore, increasing healthcare expenditures and improving access to healthcare services in developing nations is expected to boost market growth during the forecast period.

SWOT Analysis

Strength: The blood plasma derivatives market offers various life-saving products including albumin, factor VIII, factor IX and immunoglobulin. These products are used for treating rare diseases and immunodeficiencies. Some products like immunoglobulin also help boost immunity in certain patients. With high patient needs for these specialized therapeutic products, the market has steady demand.

Weakness: Manufacturing blood plasma derivatives is an expensive and complex process. Significant capital investments are required for fractionation facilities and infrastructure. Strict regulatory oversight by authorities also raise compliance costs. Collection of blood plasma from donors involves risks associated with transmissible diseases and infections that require mitigation.

Opportunity: Growing healthcare spending in emerging economies is creating new revenue avenues. Many countries are focusing on self-sufficiency in plasma supply to overcome dependence on imports. Partnerships between fractionators and collectors could help expand domestic supply. New indications and therapies using advanced derivatives can enhance the product portfolio and capture unmet needs.

Threats: stringent regulations on plasma collection can limit supply availability especially during unforeseen events. New substitutes and alternative treatment options pose competitive threats. Geopolitical uncertainties and international trade barriers also impact supply security. Economic slowdowns can temporarily affect the demand for certain products.

Key Takeaways
Global Blood Plasma Derivatives Market Size  is expected to witness high growth over the forecast period. Advancements in fractionation technologies and rising plasma collection are driving the industry expansion.

Regional analysis: Asia Pacific region is growing at the fastest pace on account of rising healthcare infrastructure, expanding patient pool and initiatives to enhance plasma self-sufficiency in countries like China and India. China in particular is focusing on building fractionation facilities, modernizing collection centers and regulating plasma sector.

Key players: Key players operating in the blood plasma derivatives market are Iron Mountain, ARC, Access, Shred-it, Restore plc, Cintas, Proshred, National Document Shredding Service, Shred Station, Red Dog Shred, Shred-X, Secured Document Shredding, Shred Works, Guardian Data Destruction, EndoShred, Mobile Shred, ShredQuick, ProShred Chicago, Shreds Unlimited. These players are focusing on expanding facilities, strategic partnerships and new product development.

Get More Insights On This Topic: https://www.newsstatix.com/blood-plasma-derivatives-market-propelled-by-increasing-demand/